Are you ready? Digital Technologies Transforming Clinical Evidence and Communicating Change
Q&A Blog Post: How Can Automation Support Literature Surveillance for Pharma and Biotechnology?
Ian Stefanison, CTO for DistillerSR, answers questions on how AI reprioritization reduces screening times by as much as 80%, according to one study.
Book a Demo
We’ll show you how DistillerSR can automate every stage of a literature review so you can produce evidence-based research faster and more accurately.